The immune response in inflammatory bowel disease

SJ Brown, L Mayer - Official journal of the American College of …, 2007 - journals.lww.com
colitis (UC) and Crohn's disease (CD), collectively referred to as inflammatory bowel disease
… While the precise mechanisms underlying the development of IBD are not known, sufficient …

Clinical aspects and pathophysiology of inflammatory bowel disease

BA Hendrickson, R Gokhale… - Clinical microbiology …, 2002 - Am Soc Microbiol
The chronic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are
recognized as important causes of gastrointestinal disease in children and adults. In this …

Risk of development of more-advanced lesions in patients with inflammatory bowel diseases and dysplasia

A Cremer, P Demetter, M De Vos, JF Rahier… - Clinical …, 2020 - Elsevier
Background & Aims Patients with inflammatory bowel diseases (IBD) have increased risks
of dysplasia and colitis-associated cancer (CAC). We evaluated the risk of development of …

A critical review of epidemiological studies in inflammatory bowel disease

F Farrokhyar, ET Swarbrick, EJ Irvine - Scandinavian journal of …, 2001 - Taylor & Francis
… association with the development of Crohn disease or ulcerative colitis (2–13) and additional
genes may well impact on both the development and the clinical course of the disease (14)…

[HTML][HTML] Role of cytokines in inflammatory bowel disease

F Sanchez-Muñoz, A Dominguez-Lopez… - World journal of …, 2008 - ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative
colitis (UC), represents a group of chronic disorders characterized by inflammation of the …

Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in …

S Cuzzocrea, R Di Paola, E Mazzon… - Laboratory …, 2004 - nature.com
… and exogenous PPAR-α ligands reduce the degree of colitis caused by DNBS. We
propose that PPAR-α ligand may be useful in the treatment of inflammatory bowel disease. …

Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy

A Schirbel, C Fiocchi - Journal of digestive diseases, 2010 - Wiley Online Library
… pave the way to a better understanding of the pro-inflammatory pathways in CD and UC
and potentially the development of specific interventions. For instance, CD patients with NOD2 …

[HTML][HTML] Environmental risk factors for inflammatory bowel disease

NA Molodecky, GG Kaplan - Gastroenterology & hepatology, 2010 - ncbi.nlm.nih.gov
… by which smoking influences the development of IBD are unknown. Nicotinic acetylcholine
receptors (nAChRs) are present in mucosal epithelial cells of the bowel. The expression of …

Novel pathophysiological concepts of inflammatory bowel disease

T Hibi, H Ogata - Journal of gastroenterology, 2006 - Springer
… They found that intake of fast foods containing large amounts of fat and sugarrich foods may
accelerate the development of CD. Another study demonstrated that long-chain fatty acids …

[HTML][HTML] Immunological pathogenesis of inflammatory bowel disease

SH Lee, J eun Kwon, ML Cho - Intestinal research, 2018 - synapse.koreamed.org
Inflammatory bowel disease (IBD) is a chronic inflammatory state of the gastrointestinal tract
and can be classified into 2 main clinical phenomena: Crohn's disease (CD) and ulcerative …